Cellebrite DI Ltd (NASDAQ: CLBT) on Friday, plunged -2.28% from the previous trading day, before settling in for the closing price of $20.18. Within the past 52 weeks, CLBT’s price has moved between $7.91 and $21.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Technology sector was 18.79%. The company achieved an average annual earnings per share of -218.60%. With a float of $86.02 million, this company’s outstanding shares have now reached $203.23 million.
Considering the fact that the conglomerate employs 1008 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 84.45%, operating margin of 14.59%, and the pretax margin is -80.02%.
Cellebrite DI Ltd (CLBT) Breakdown of a Key Holders of the stock
Observing investor behavior towards Software – Infrastructure industry stocks is more important than anything else. The insider ownership of Cellebrite DI Ltd is 58.66%, while institutional ownership is 38.72%. The most recent insider transaction that took place on Nov 22 ’24, was worth 13,908,682. Before that another transaction happened on Nov 19 ’24, when Company’s Officer proposed sale 37,909 for $18.50, making the entire transaction worth $701,316.
Cellebrite DI Ltd (CLBT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -218.60% per share during the next fiscal year.
Cellebrite DI Ltd (NASDAQ: CLBT) Trading Performance Indicators
Cellebrite DI Ltd (CLBT) is currently performing well based on its current performance indicators. A quick ratio of 1.78 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.41. Likewise, its price to free cash flow for the trailing twelve months is 39.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.55, a number that is poised to hit 0.06 in the next quarter and is forecasted to reach 0.26 in one year’s time.
Technical Analysis of Cellebrite DI Ltd (CLBT)
Compared to the last year’s volume of 1.18 million, its volume of 1.77 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 87.50%. Additionally, its Average True Range was 0.79.
During the past 100 days, Cellebrite DI Ltd’s (CLBT) raw stochastic average was set at 86.57%, which indicates a significant increase from 65.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.37% in the past 14 days, which was higher than the 38.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.97, while its 200-day Moving Average is $13.75. Nevertheless, the first resistance level for the watch stands at $20.20 in the near term. At $20.68, the stock is likely to face the second major resistance level. The third major resistance level sits at $20.92. If the price goes on to break the first support level at $19.47, it is likely to go to the next support level at $19.22. Now, if the price goes above the second support level, the third support stands at $18.74.
Cellebrite DI Ltd (NASDAQ: CLBT) Key Stats
Market capitalization of the company is 4.01 billion based on 205,932K outstanding shares. Right now, sales total 325,110 K and income totals -81,100 K. The company made 106,860 K in profit during its latest quarter, and -207,090 K in sales during its previous quarter.
